The purpose of the present study was to test the possible utility of fractal analysis from MET uptake in patients with newly diagnosed gliomas for differentiating glioma, especially in relation to IDH1 mutation status, in a comparison with the conventional SUV parameters. Here, IDH1 is linked to central nervous system cancer.